How to investigate secondary causes of hypertension as per European Society of Cardiology (ESC) guidelines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

To investigate secondary causes of hypertension, start with a comprehensive clinical assessment and basic laboratory tests, and proceed with targeted investigations based on suggestive signs, symptoms, or medical history, as recommended by the 2024 ESC guidelines 1. When evaluating patients with hypertension, it is essential to consider secondary causes, as identifying the underlying cause can lead to specific treatments or even cure, rather than lifelong antihypertensive therapy.

Initial Assessment

The initial assessment should include a detailed history, physical examination, and basic laboratory tests, such as urinalysis, blood chemistry (sodium, potassium, creatinine, glucose), lipid profile, and 12-lead ECG.

Targeted Investigations

For patients with features suggesting secondary hypertension, such as young age, sudden onset, resistant hypertension, or specific symptoms, proceed with targeted investigations.

  • For primary aldosteronism, measure aldosterone-to-renin ratio 1;
  • For renal artery stenosis, use duplex ultrasound followed by CT or MR angiography 1;
  • For pheochromocytoma, measure plasma or urinary metanephrines 1;
  • For Cushing's syndrome, perform overnight dexamethasone suppression test 1;
  • For obstructive sleep apnea, use screening questionnaires and sleep studies 1;
  • For renal parenchymal disease, check renal function, urinalysis, and renal ultrasound 1. Thyroid function tests should be performed when clinically indicated 1.

Recent Guidelines

The 2024 ESC guidelines recommend screening for secondary hypertension in patients with suggestive signs, symptoms, or medical history, and also advise considering screening for primary aldosteronism by renin and aldosterone measurements in all adults with confirmed hypertension 1.

Patient-Specific Approach

A patient-specific approach is essential, taking into account the individual's medical history, symptoms, and physical examination findings to guide targeted investigations. By following these recommendations and guidelines, clinicians can effectively investigate secondary causes of hypertension and provide personalized care to their patients, ultimately improving morbidity, mortality, and quality of life outcomes.

From the Research

Investigating Secondary Causes of Hypertension

To investigate secondary causes of hypertension as per ESC guidelines, the following steps can be taken:

  • Identify patients with resistant hypertension, hypokalemia, or onset of hypertension at a young age 2, 3, 4, 5
  • Perform a thorough medical history and physical examination to look for signs and symptoms of secondary hypertension 2, 3, 4
  • Conduct laboratory tests such as plasma aldosterone concentration (PAC) to plasma renin activity (PRA) ratio, fractionated metanephrines, and catecholamines to diagnose primary aldosteronism and pheochromocytoma 6, 5
  • Use imaging studies such as abdominal CT and 18F-FDOPA PET-CT to localize adrenal lesions 6
  • Consider referral to a specialist for further evaluation and management if secondary hypertension is suspected 4

Common Causes of Secondary Hypertension

Some common causes of secondary hypertension include:

  • Primary aldosteronism 6, 2, 3, 5
  • Pheochromocytoma 6, 5
  • Renovascular hypertension 2, 3
  • Obstructive sleep apnea 2, 3
  • Drug-induced hypertension 2, 3

Diagnostic Strategies

Diagnostic strategies for secondary hypertension may involve:

  • Biochemical testing such as PAC/PRA ratio and fractionated metanephrines 6, 5
  • Imaging studies such as abdominal CT and 18F-FDOPA PET-CT 6
  • Aldosterone suppression testing with oral or intravenous sodium loading 5
  • Captopril test to confirm primary aldosteronism 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation and Management of Secondary Hypertension.

The Medical clinics of North America, 2022

Research

The Demystification of Secondary Hypertension: Diagnostic Strategies and Treatment Algorithms.

Current treatment options in cardiovascular medicine, 2019

Research

Secondary causes of hypertension.

Primary care, 2008

Research

Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism.

Reviews in endocrine & metabolic disorders, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.